Propensity-adjusted 8-year outcomes following bioprosthetic aortic valve replacement: The influence of novel anticalcification technologyCentral MessagePerspective
Objective: Aortic bioprostheses with RESILIA (Edwards Lifesciences) tissue technology have demonstrated robust outcomes through 7 years of follow-up. However, studies comparing RESILIA tissue valve outcomes to previous bioprosthetic valves are lacking. We sought to assess surgical aortic valve repla...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-02-01
|
| Серія: | JTCVS Open |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2666273625004887 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|